https://peptaven.com/learn Straight answers on peptide regulation, safety, and science — from the team building a clinician-guided peptide therapy platform. en-us https://peptaven.com/learn/fda-peptide-vote-2026 https://peptaven.com/learn/fda-peptide-vote-2026 Mon, 03 Aug 2026 12:00:00 GMT An FDA advisory committee recommended six peptides for the 503A compounding list. What that means, what it doesn't, and why nothing is legal yet. https://peptaven.com/learn/is-bpc-157-legal https://peptaven.com/learn/is-bpc-157-legal Mon, 03 Aug 2026 12:00:00 GMT The Category 2 removal, the close 8-6 committee vote, what the research supports, and why "research use only" isn't a legal path. https://peptaven.com/learn/are-peptides-legal https://peptaven.com/learn/are-peptides-legal Mon, 03 Aug 2026 12:00:00 GMT The three legal lanes every peptide falls into, and how to tell which one you're standing in. https://peptaven.com/learn/how-to-vet-a-peptide-provider https://peptaven.com/learn/how-to-vet-a-peptide-provider Mon, 03 Aug 2026 12:00:00 GMT Six questions that separate real, provider-guided therapy from gray-market risk.